Performance of AZN AstraZeneca PLC ADR | 5.2% in 12m
Compare AZN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare AstraZeneca PLC ADR with its related Sector/Index XLV
Performance Duell AZN vs XLV
| TimeFrame | AZN | XLV |
|---|---|---|
| 1 Day | -0.18% | 0.19% |
| 1 Week | -0.36% | 1.89% |
| 1 Month | 12.2% | 5.68% |
| 3 Months | 21.5% | 0.84% |
| 6 Months | 21.8% | 15.01% |
| 12 Months | 5.21% | 13.50% |
| YTD | 14.2% | 5.81% |
| Rel. Perf. 1m | 0.66 | |
| Rel. Perf. 3m | 0.78 | |
| Rel. Perf. 6m | 0.66 | |
| Rel. Perf. 12m | -0.71 |
Is AstraZeneca PLC ADR a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, AstraZeneca PLC ADR (NASDAQ:AZN) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.13 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZN as of May 2024 is 77.94. This means that AZN is currently overvalued and has a potential downside of 1.35% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZN as of May 2024 is 77.94. This means that AZN is currently overvalued and has a potential downside of 1.35% (Sold with Premium).
Is AZN a buy, sell or hold?
- Strong Buy: 7
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: AZN is performing better - Values below 0%: AZN is underperforming
Compare AZN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.01% | 6.44% | 3.47% | -24.14% |
| US NASDAQ 100 | QQQ | -2.55% | 6.12% | 4.29% | -32.14% |
| US Dow Jones Industrial 30 | DIA | -1.72% | 6.04% | 6.29% | -16.81% |
| German DAX 40 | DBXD | 0.04% | 7.24% | 4.77% | -11.56% |
| UK FTSE 100 | ISFU | -1.86% | 2.41% | 4.90% | -10.16% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.47% | 7.69% | 18.43% | 12.88% |
| Hongkong Hang Seng | HSI | -4.09% | -11.07% | 16.72% | 10.57% |
| Japan Nikkei 225 | EXX7 | -0.73% | 12.71% | 10.27% | -6.60% |
| India NIFTY 50 | INDA | -3.47% | 8.29% | 4.18% | -23.51% |
| Brasil Bovespa | EWZ | -0.80% | 6.97% | 23.59% | -7.12% |
AZN AstraZeneca PLC ADR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.36% | 8.90% | 3.25% | -32.27% |
| Consumer Discretionary | XLY | -0.70% | 8.51% | 14.42% | -14.46% |
| Consumer Staples | XLP | -1.12% | 5.63% | 7.52% | -0.37% |
| Energy | XLE | -1.56% | 11.33% | 7.64% | -20.01% |
| Financial | XLF | -1.94% | 5.16% | -0.66% | -27.86% |
| Health Care | XLV | -2.25% | 6.53% | 6.75% | -8.29% |
| Industrial | XLI | -0.08% | 8.73% | 2.07% | -23.12% |
| Materials | XLB | -0.70% | 8.67% | 5.74% | -15.41% |
| Real Estate | XLRE | -2.87% | 3.73% | 12.12% | -4.77% |
| Technology | XLK | -3.42% | 5.69% | 5.44% | -33.10% |
| Utilities | XLU | -1.86% | -0.68% | 3.56% | -7.47% |
| Aerospace & Defense | XAR | -1.13% | 3.75% | 6.22% | -18.94% |
| Biotech | XBI | -3.81% | 4.50% | -3.75% | -1.16% |
| Homebuilder | XHB | -0.04% | 5.87% | -8.75% | -45.64% |
| Retail | XRT | -2.44% | 4.75% | 0.92% | -19.98% |
Does AstraZeneca PLC ADR outperform its market, is AZN a Sector Leader?
No, over the last 12 months AstraZeneca PLC ADR (AZN) made 5.21%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.50%.
Over the last 3 months AZN made 21.49%, while XLV made 0.84%.
No, over the last 12 months AstraZeneca PLC ADR (AZN) made 5.21%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.50%.
Over the last 3 months AZN made 21.49%, while XLV made 0.84%.
| Period | AZN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 12.21% | 5.68% | 5.77% |
| 3 Months | 21.49% | 0.84% | 6.32% |
| 12 Months | 5.21% | 13.50% | 29.35% |